About Us

 

Rhein Biotech GmbH is dedicated to developing and manufacturing vaccines and biopharmaceutical products from bench to market. Together with our partners, we develop and manufacture vaccines, adjuvants, and immuno-therapeutics.

Our integrated product development services have enabled our partners to bring to market products which include hepatitis B vaccines, combination vaccines, human insulin, human IFNα-2a and hirudin. In addition, our services currently support several vaccines and innovative biopharmaceutical products that are in clinical development or close to registration.

With over 20 years of experience, we have significant expertise in technology development, EU-licensed GMP manufacturing and project management.

We use our product development expertise to integrate our services into our partners’ programs, from preclinical through clinical development and to support commercial manufacturing.

Our proprietary technology platforms are available for our partners to license non-exclusively for worldwide use. We take an integrated approach to strain, process and analytical development to generate a robust industrial GMP process. In addition, we provide expert immunology and strain characterization services and testing of clinical samples.

Rhein Biotech GmbH is headquartered in Düsseldorf, Germany and is a subsidiary of Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company.

Rhein Biotech GmbH
Dynavax Europe
Eichsfelder Strasse 11
D-40595 Düsseldorf

Phone: +49 (0)211 7 58 45 0
Fax: +49 (0)211 7 58 45 130
E-Mail: info(at)rheinbiotech.de